Anhui: new crown infection outpatient cost reimbursement ratio unified for 70%
According to the Anhui Provincial Bureau of Medical Protection news, December 29, 2022, Anhui Provincial Bureau of Medical Protection, Anhui Provincial Department of Finance, Anhui Provincial Health Health Commission jointly issued an emergency notice on the new coronavirus infection outpatient treatment guarantee work, the new coronavirus infection outpatient treatment guarantee work, the new coronavirus infection outpatient treatment guarantee work. Clearly insured persons new coronary infection in the coordinated area of ordinary outpatient (emergency) clinic treatment, occurring in line with the new coronary virus pneumonia diagnosis and treatment program and other provisions of the medical costs, into the basic health insurance fund to pay the scope of the integrated fund, does not set a starting line, reimbursement limit, reimbursement ratio of 70%.Hebei Sanhe released the new coronavirus infected people health insurance reimbursement policy understand paper
According to the "civilization of the three rivers" public news, Sanhe City, Hebei Province, the Medical Protection Bureau has recently released the "new coronavirus infected people health insurance reimbursement policy understand paper", clear employee health insurance outpatient The annual starting standard is 100 yuan, under 45 years old, the proportion of payment of the integrated fund is 60%, the annual payment limit is 2000 yuan; 45 years old (including) and above, the proportion of payment of the integrated fund is 60%, the annual payment limit is 3,000 yuan; the proportion of payment of the integrated fund of the retirees is 70%, the annual payment limit is 4,000 yuan.Fujian Jinjiang: outpatient, hospitalization can be reimbursed
According to Jinjiang News Network news, Jinjiang City, Fujian Province, the infection of the new crown after the health insurance reimbursement matters issued a notice: outpatient, the insured person, if the health insurance designated primary health care institutions, you can enjoy the treatment of the general outpatient. In the township health center (community health service center), the reimbursement rate of 70%, the maximum payment limit of 420 yuan; in the city's designated village medical institutions, the reimbursement rate of 50%, the maximum payment limit of 50 yuan (a single reimbursement limit of 10 yuan). For hospitalization, the basic medical insurance will reimburse 80% of the reimbursement amount for medical expenses incurred in designated medical institutions outside the city and province, and 60% of the reimbursement amount for medical expenses incurred in designated medical institutions outside the province.Shandong: new crown symptoms online consultation into the medical insurance reimbursement
According to the Shandong Provincial Bureau of Medical Protection website news, Shandong Provincial Bureau of Medical Protection, Shandong Provincial Health Health Committee recently jointly issued a "do a good job on the new coronary virus infection Internet medical insurance service notice", pointed out that the new crown related symptoms Internet consultation fee into the basic medical insurance payment scope, the new crown related symptoms, the new crown related symptoms Internet consultation fee into the new coronary virus infection. The basic medical insurance payment scope, and offline reimbursement policy is consistent. The medical insurance department should promptly settle and pay the "Internet +" medical expenses, strengthen the intelligent audit, and promote the rational and standardized use of medical insurance funds.Beijing: Nematodevir tablets / ritonavir tablets and other six drugs temporarily included in the medical insurance
In response to the new situation of the epidemic, the Beijing Municipal Bureau of Medical Insurance, with the approval of the State Medical Insurance Bureau, will be compound aminophenol alkylamine capsule, compound aminophenol meglumine oral solution, pediatric aminophenol xanthanamine particles, aminocarbazide capsules, chlorphenesulfamethoxazole tablets, aminoglutethimide oral solution six drugs temporarily included in the Beijing Municipal Medical Insurance Bureau, with the approval of the State Medical Insurance Bureau, the Beijing Municipal Bureau of Medical Insurance. The six medicines are temporarily included in the reimbursement scope of Beijing medical insurance and industrial injury insurance, and the reimbursement rate is in accordance with Class A medicines. The reimbursement rate will be in accordance with the reimbursement rate of Class A drugs. The reimbursement rate will be implemented from December 18, 2022, and will be valid until March 18, 2023. In addition, in order to increase the rescue and treatment of patients who may develop serious and critical illnesses after the new crown infection, recently, Nematrevir tablets / ritonavir tablets have also been included in the reimbursement scope of the Beijing Municipal Health Insurance Drugs, and the reimbursement rate of Beijing community hospitals is 90%.Shaanxi: 234 kinds of new crown medicines are temporarily included in the medical insurance
According to the "health Shaanxi release" news, recently, Shaanxi Provincial Medical Protection Bureau, Shaanxi Provincial Health Health Commission, the State Administration of Taxation of Shaanxi Provincial Taxation Bureau of the three units jointly issued the "on the further improvement of the current epidemic prevention and control of medical care and health care", the State Administration of Taxation of Shaanxi Provincial Taxation Bureau. Do a good job in the current epidemic prevention and control of medical support work notice", will be confirmed and suspected patients to use "Shaanxi Provincial Health Health Commission Shaanxi Provincial Administration of Traditional Chinese Medicine on the issuance of the Shaanxi Province, the new coronavirus infection Chinese medicine prevention program (third edition) and treatment program (trial version of the fourth edition) of the notice" recommended by the 107 types of proprietary Chinese medicines, and the provincial drug supervision bureau, the Provincial Health Commission to organize the expert selection of the new coronavirus condition targeted, treatment effect of 127 types of more pronounced. The two types of 127 medicines that are more obvious are temporarily included in the scope of medical insurance payment, and the medical insurance payment will be made until June 30, 2023, so as to guarantee the medication for diagnosed and suspected patients.Hubei: 36 kinds of new coronary drugs temporarily included in the health insurance
Hubei Provincial Bureau of Medical Security December 29, 2022 news, approved by the State Medical Security Bureau, since December 29, 2022, pediatric aminophenol huangnamin particles, cotrimoxazole syrup, and other 36 kinds of new coronary viruses drugs temporarily included in the Hubei Provincial Medical Insurance reimbursement category, reimbursement, and the number of patients who have been diagnosed and suspected of using drugs. Medical insurance reimbursement category, reimbursement rate in accordance with the implementation of Category A drugs.Yunnan: 41 medicines have been temporarily included in the medical insurance
The Yunnan Provincial Bureau of Medical Protection released a news on December 30, 2022, "Yunnan Province, the new coronavirus infected people with medication catalog (trial the first version)," "Sang Ju Yin Qiao San," 41 medicines have been temporarily included in the medical insurance payment scope. Temporarily included in the scope of payment of medical insurance, according to the management of Class A drugs, to further meet the needs of the people to buy drugs, reduce the cost burden of patients with new coronary infection.Guangxi: 15 kinds of new crown medicines can brush health insurance
According to the news of Guangxi News, in order to further protect the masses of medication needs, the autonomous region of the Medical Protection Bureau of the external wind cholera particles and other 15 kinds of medicines are temporarily included in the region's basic medical insurance fund payment scope, according to the health insurance class A drugs reimbursement, since December 22, 2022 onwards. The validity period is until March 22, 2023.